DE69932939T2 - Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen - Google Patents

Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen Download PDF

Info

Publication number
DE69932939T2
DE69932939T2 DE69932939T DE69932939T DE69932939T2 DE 69932939 T2 DE69932939 T2 DE 69932939T2 DE 69932939 T DE69932939 T DE 69932939T DE 69932939 T DE69932939 T DE 69932939T DE 69932939 T2 DE69932939 T2 DE 69932939T2
Authority
DE
Germany
Prior art keywords
acid
oxifulvic
fulvic
oxifulvic acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932939T
Other languages
German (de)
English (en)
Other versions
DE69932939D1 (de
Inventor
Johannes Dekker
Elizabeth Constance MEDLEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfeinsmith Ltd
Original Assignee
Pfeinsmith Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfeinsmith Ltd filed Critical Pfeinsmith Ltd
Publication of DE69932939D1 publication Critical patent/DE69932939D1/de
Application granted granted Critical
Publication of DE69932939T2 publication Critical patent/DE69932939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69932939T 1998-10-08 1999-10-08 Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen Expired - Lifetime DE69932939T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA9809190 1998-10-08
ZA989190 1998-10-08
ZA9902848 1999-04-21
ZA992848 1999-04-21
PCT/IB1999/001649 WO2000019999A1 (en) 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions

Publications (2)

Publication Number Publication Date
DE69932939D1 DE69932939D1 (de) 2006-10-05
DE69932939T2 true DE69932939T2 (de) 2006-12-07

Family

ID=27144980

Family Applications (4)

Application Number Title Priority Date Filing Date
DE69939720T Expired - Lifetime DE69939720D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von viralen Infektionen
DE69939722T Expired - Lifetime DE69939722D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von Entzündungen
DE69939721T Expired - Lifetime DE69939721D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von Candida Infektionen
DE69932939T Expired - Lifetime DE69932939T2 (de) 1998-10-08 1999-10-08 Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE69939720T Expired - Lifetime DE69939720D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von viralen Infektionen
DE69939722T Expired - Lifetime DE69939722D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von Entzündungen
DE69939721T Expired - Lifetime DE69939721D1 (de) 1998-10-08 1999-10-08 Fulvinsäure und deren Verwendung in der Behandlung von Candida Infektionen

Country Status (7)

Country Link
US (1) US6569900B1 (enExample)
EP (4) EP1700599B1 (enExample)
JP (1) JP4700808B2 (enExample)
AT (4) ATE410158T1 (enExample)
AU (1) AU766198B2 (enExample)
DE (4) DE69939720D1 (enExample)
WO (1) WO2000019999A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570565C (en) * 2004-06-23 2012-10-23 Bioz Agri Products Inc. Method for extracting fulvic acid molecules
RU2280458C1 (ru) * 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
WO2006064449A1 (en) * 2004-12-15 2006-06-22 Van Der Westhuizen Cornelis Fl Detoxifying and immunity-booster composition
US20080160111A1 (en) * 2005-02-28 2008-07-03 Hiroko Isoda Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid
JP2006232785A (ja) * 2005-02-28 2006-09-07 Univ Of Tsukuba フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
BRPI0709711A2 (pt) 2006-05-02 2011-07-26 Pfeinsmith S A Pty Ltd composiÇço, e, mÉtodo de fabricar a mesma.
CN102099027B (zh) 2008-06-05 2012-12-12 皮费恩史密斯有限公司 富里酸及抗生素组合物
DE102008058552A1 (de) 2008-11-21 2010-05-27 Mankau, Dieter, Prof. Dr. Federrahmen und Federkörper zur Abstützung z. B. einer Matratze
GB0900786D0 (en) 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
GB0914966D0 (en) * 2009-08-27 2009-09-30 Natracine Uk Ltd Fulvic acid compositions and their use
WO2013023062A1 (en) * 2011-08-09 2013-02-14 Wilford Lynn C Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms
US9265744B2 (en) * 2012-03-07 2016-02-23 Natracine Uk Limited Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
CN105246879A (zh) 2013-05-28 2016-01-13 英派尔科技开发有限公司 腐植酸衍生物以及制备的方法和用途
EP3004070B1 (en) 2013-05-28 2017-10-11 Empire Technology Development LLC Antioxidant humic acid derivatives and methods of preparation and use
WO2014209369A1 (en) 2013-06-28 2014-12-31 Empire Technology Development Llc Edible plasticizers for food and food packaging films
WO2017102565A1 (en) * 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
US9820953B2 (en) * 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof
JP6120342B1 (ja) * 2016-03-08 2017-04-26 株式会社スタイルアンドバリュージャパン 美容組成物
CN113924084A (zh) * 2019-03-20 2022-01-11 瑞塔·多布迈尔 药物组合物
EP3799854A1 (en) 2019-10-01 2021-04-07 Stefan Johannes Fellner Extract of organic humified materials
WO2021226627A1 (en) * 2020-05-05 2021-11-11 Figene, Llc Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof
KR102258006B1 (ko) * 2020-12-22 2021-05-28 허교 풀빅산을 유효성분으로 포함하는 항바이러스 조성물
CN117064913A (zh) * 2023-02-23 2023-11-17 单士军 用于缓解特应性皮炎的黄腐酸外用制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB244215A (en) 1924-10-09 1925-12-17 Richard William Bailey Improvements in or relating to gas or oil power plant
DE2850685A1 (de) * 1978-11-22 1980-06-04 Kneer Franz X Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung
US5204368A (en) * 1990-05-25 1993-04-20 National Energy Council Bacteriostatic and bacteriocidal method using fulvic acid derivatives
JPH0466508A (ja) * 1990-07-03 1992-03-02 Suntory Ltd 抗菌剤
JPH0687752A (ja) * 1992-09-04 1994-03-29 Kyowa Kagaku Kogyo Kk 抗菌水及びこの抗菌水の製造方法
CN1097990A (zh) * 1994-01-29 1995-02-01 康宏盛 一种治疗股癣的药物
JPH1017483A (ja) * 1996-06-26 1998-01-20 Keinzu Corp:Kk 皮膚疾患予防及び治療剤
AP9801415A0 (en) * 1996-06-27 1998-12-31 Organoflo Pty Ltd A method of making a liquid fertilizing substance.
JPH119674A (ja) * 1997-06-25 1999-01-19 M S K Planning:Kk フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法
CN1103339C (zh) * 1998-08-25 2003-03-19 祝亚勤 药用级泥炭黄腐植酸钠的制备方法

Also Published As

Publication number Publication date
AU766198B2 (en) 2003-10-09
ATE410158T1 (de) 2008-10-15
ATE410159T1 (de) 2008-10-15
EP1700599A1 (en) 2006-09-13
EP1700600A1 (en) 2006-09-13
DE69939720D1 (de) 2008-11-20
DE69932939D1 (de) 2006-10-05
US6569900B1 (en) 2003-05-27
DE69939721D1 (de) 2008-11-20
AU5992399A (en) 2000-04-26
ATE410160T1 (de) 2008-10-15
EP1698333A1 (en) 2006-09-06
ATE336997T1 (de) 2006-09-15
JP4700808B2 (ja) 2011-06-15
DE69939722D1 (de) 2008-11-20
WO2000019999A1 (en) 2000-04-13
EP1700600B1 (en) 2008-10-08
EP1126837B1 (en) 2006-08-23
EP1700599B1 (en) 2008-10-08
EP1126837A1 (en) 2001-08-29
EP1698333B1 (en) 2008-10-08
JP2002526407A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
DE69932939T2 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69837348T2 (de) Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen
DE69532469T2 (de) Adhäsion inhibierender Vaccinium Extrakt
DE69737144T2 (de) Antimikrobielle behandlung von herpes simplex viren und anderer infektioser erkrankungen
DE60310377T2 (de) Lang wirksame, parasiten-abtötende zubereitung enthaltend eine salicylanilid verbindung, eine polymere verbindung und mindestens eine weitere parasiten-abtötende verbindung
DE69920201T2 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
DE68904922T2 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
DE2832204A1 (de) Mittel zur behandlung von nervenerkrankungen, verfahren zu seiner herstellung und seine verwendung
EP0252276A2 (de) Desinfektions- und Reinigungsmittel
DE2526998A1 (de) Ophthalmische loesung
DE60034898T2 (de) Antiallergische Zusammensetzung, die OLIGOSACCHARIDe und eine Saponine oder eine basische Aminosäure enthält, zur topischen Verabreichung oder Inhalation
DE4321444A1 (de) Pharmazeutische Zubereitung
DE69006046T2 (de) Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen.
DE2631947A1 (de) Konservierung von basischen arzneimittelzubereitungen
DE2338031A1 (de) Antimikrobielle komposition
EP2047855B1 (de) Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)
DE69003960T2 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
DE1768655B2 (enExample)
WO1998058639A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
EP0450123A1 (de) Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung
DE69428120T2 (de) Lokal anwendbares präparat zur reepithelisierung bei andauernden epitheldefekten
AT398883B (de) In der tierzucht verwendetes präparat sowie verfahren zu dessen herstellung
EP0194466A2 (de) Kombination zur antimikrobiellen und antioxidativen Stabilisierung von Externa und Körperpflegemitteln
EP3290044A1 (de) Antibakterielle zusammensetzung, umfassend einen pflanzenextrakt, verfahren zur gewinnung des extrakts, pharmazeutische zusammensetzung und deren verwendung
DE69528922T2 (de) Herstellung von 2-Bromo-5-(2-bromo-2-nitro-vinyl)-furan und deren Verwendung als Microzide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition